Cancer Curing and Vaccination
Nanotechnologies to help in new cancer treatment strategy
ULISES is set to develop an immunologic-based treatment strategy where cancer cells are reprogrammed to become “visible” to the patients’ immune system.
According to the statistics from the World Health Organization, cancer is the second leading cause of death globally, counting for approximately 9.6 million deaths in 2018. This figure is expected to increase by 60% by 2040 due to the ageing and increase of the world’s population.
While cancer treatments are currently based on surgical resection of the tumour (if possible), chemotherapy, radiotherapy, target-driven therapies and immunotherapy, ULISES aims to set out an all-new therapeutic strategy based on nanotechnologies.
RT @EuropeanCancer: ⚠️The European #CodeOfCancerPractice is a long lasting tool to be used in improving #cancercare and patient rights✊ 🌎T…
RT @EPHA_EU: “To realise the full potential of the #EUCancerPlan, the nursing community should be included as equal partners in education a…